01/2007
FS0103 (IIa) clinical trial of Sifuvirtide completed

11/2006
FS0102 (Ib) clinical trial of Sifuvirtide completed

06/2006
Phase II clinical trials of Sifuvirtide approved by SFDA

02/2006
FS0101 (Ia) clinical trial of Sifuvirtide completed

11/2005
The patent of Sifuvirtide issued by US Patent and Trademark Office

04/2005
Phase I clinical trials of Sifuvirtide approved by SFDA

02/2003
The patent of Sifuvirtide issued in China

02/2002
FusoGen Pharmaceuticals, Inc. founded in Tianjin, China